JPS63152564A - Various packaged medicine - Google Patents
Various packaged medicineInfo
- Publication number
- JPS63152564A JPS63152564A JP29121486A JP29121486A JPS63152564A JP S63152564 A JPS63152564 A JP S63152564A JP 29121486 A JP29121486 A JP 29121486A JP 29121486 A JP29121486 A JP 29121486A JP S63152564 A JPS63152564 A JP S63152564A
- Authority
- JP
- Japan
- Prior art keywords
- laminated
- contents
- drug
- aluminum foil
- sealing member
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title description 24
- 238000007789 sealing Methods 0.000 claims description 15
- 239000005022 packaging material Substances 0.000 claims description 13
- 238000004806 packaging method and process Methods 0.000 claims description 11
- 229920005992 thermoplastic resin Polymers 0.000 claims description 10
- 238000002360 preparation method Methods 0.000 claims description 8
- 229940079593 drug Drugs 0.000 description 21
- 229910052782 aluminium Inorganic materials 0.000 description 16
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 16
- 239000011888 foil Substances 0.000 description 15
- 239000000126 substance Substances 0.000 description 15
- 239000011248 coating agent Substances 0.000 description 8
- 238000000576 coating method Methods 0.000 description 8
- 239000007787 solid Substances 0.000 description 8
- -1 polyethylene Polymers 0.000 description 7
- 239000004800 polyvinyl chloride Substances 0.000 description 6
- 229920000915 polyvinyl chloride Polymers 0.000 description 6
- 239000004698 Polyethylene Substances 0.000 description 5
- 230000006866 deterioration Effects 0.000 description 5
- 238000002845 discoloration Methods 0.000 description 5
- 239000012530 fluid Substances 0.000 description 5
- 238000003475 lamination Methods 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 229920000573 polyethylene Polymers 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- 230000007797 corrosion Effects 0.000 description 4
- 238000005260 corrosion Methods 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 229920001684 low density polyethylene Polymers 0.000 description 4
- 239000004702 low-density polyethylene Substances 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 239000000853 adhesive Substances 0.000 description 3
- 230000001070 adhesive effect Effects 0.000 description 3
- 238000001125 extrusion Methods 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 239000003566 sealing material Substances 0.000 description 3
- 238000007711 solidification Methods 0.000 description 3
- 230000008023 solidification Effects 0.000 description 3
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 239000011247 coating layer Substances 0.000 description 2
- 239000012528 membrane Substances 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 230000035699 permeability Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- FDDDEECHVMSUSB-UHFFFAOYSA-N sulfanilamide Chemical compound NC1=CC=C(S(N)(=O)=O)C=C1 FDDDEECHVMSUSB-UHFFFAOYSA-N 0.000 description 2
- 229940124530 sulfonamide Drugs 0.000 description 2
- SIACJRVYIPXFKS-UHFFFAOYSA-N (4-sulfamoylphenyl)methylazanium;chloride Chemical compound Cl.NCC1=CC=C(S(N)(=O)=O)C=C1 SIACJRVYIPXFKS-UHFFFAOYSA-N 0.000 description 1
- CIVCELMLGDGMKZ-UHFFFAOYSA-N 2,4-dichloro-6-methylpyridine-3-carboxylic acid Chemical compound CC1=CC(Cl)=C(C(O)=O)C(Cl)=N1 CIVCELMLGDGMKZ-UHFFFAOYSA-N 0.000 description 1
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
- IYLLULUTZPKQBW-UHFFFAOYSA-N Acrinol Chemical compound CC(O)C(O)=O.C1=C(N)C=CC2=C(N)C3=CC(OCC)=CC=C3N=C21 IYLLULUTZPKQBW-UHFFFAOYSA-N 0.000 description 1
- 238000003855 Adhesive Lamination Methods 0.000 description 1
- 240000008100 Brassica rapa Species 0.000 description 1
- 229920000298 Cellophane Polymers 0.000 description 1
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
- DBAKFASWICGISY-BTJKTKAUSA-N Chlorpheniramine maleate Chemical compound OC(=O)\C=C/C(O)=O.C=1C=CC=NC=1C(CCN(C)C)C1=CC=C(Cl)C=C1 DBAKFASWICGISY-BTJKTKAUSA-N 0.000 description 1
- ITRJWOMZKQRYTA-RFZYENFJSA-N Cortisone acetate Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)COC(=O)C)(O)[C@@]1(C)CC2=O ITRJWOMZKQRYTA-RFZYENFJSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- BALXUFOVQVENIU-GNAZCLTHSA-N Ephedrine hydrochloride Chemical compound Cl.CN[C@@H](C)[C@H](O)C1=CC=CC=C1 BALXUFOVQVENIU-GNAZCLTHSA-N 0.000 description 1
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- HCBIBCJNVBAKAB-UHFFFAOYSA-N Procaine hydrochloride Chemical compound Cl.CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 HCBIBCJNVBAKAB-UHFFFAOYSA-N 0.000 description 1
- 229920003182 Surlyn® Polymers 0.000 description 1
- MZVQCMJNVPIDEA-UHFFFAOYSA-N [CH2]CN(CC)CC Chemical group [CH2]CN(CC)CC MZVQCMJNVPIDEA-UHFFFAOYSA-N 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000001467 acupuncture Methods 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical group [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 229940030225 antihemorrhagics Drugs 0.000 description 1
- 229940125715 antihistaminic agent Drugs 0.000 description 1
- 239000000739 antihistaminic agent Substances 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- 229960005274 benzocaine Drugs 0.000 description 1
- BLFLLBZGZJTVJG-UHFFFAOYSA-N benzocaine Chemical compound CCOC(=O)C1=CC=C(N)C=C1 BLFLLBZGZJTVJG-UHFFFAOYSA-N 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 1
- 239000004327 boric acid Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229960003333 chlorhexidine gluconate Drugs 0.000 description 1
- YZIYKJHYYHPJIB-UUPCJSQJSA-N chlorhexidine gluconate Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O.C1=CC(Cl)=CC=C1NC(=N)NC(=N)NCCCCCCNC(=N)NC(=N)NC1=CC=C(Cl)C=C1 YZIYKJHYYHPJIB-UUPCJSQJSA-N 0.000 description 1
- 229940046978 chlorpheniramine maleate Drugs 0.000 description 1
- IVHBBMHQKZBJEU-UHFFFAOYSA-N cinchocaine hydrochloride Chemical compound [Cl-].C1=CC=CC2=NC(OCCCC)=CC(C(=O)NCC[NH+](CC)CC)=C21 IVHBBMHQKZBJEU-UHFFFAOYSA-N 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 238000010411 cooking Methods 0.000 description 1
- 229960003290 cortisone acetate Drugs 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- LTNZEXKYNRNOGT-UHFFFAOYSA-N dequalinium chloride Chemical compound [Cl-].[Cl-].C1=CC=C2[N+](CCCCCCCCCC[N+]3=C4C=CC=CC4=C(N)C=C3C)=C(C)C=C(N)C2=C1 LTNZEXKYNRNOGT-UHFFFAOYSA-N 0.000 description 1
- 229960001378 dequalinium chloride Drugs 0.000 description 1
- 239000000645 desinfectant Substances 0.000 description 1
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 1
- 229960003657 dexamethasone acetate Drugs 0.000 description 1
- 229940045574 dibucaine hydrochloride Drugs 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229960000525 diphenhydramine hydrochloride Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 229960003720 enoxolone Drugs 0.000 description 1
- 229960002534 ephedrine hydrochloride Drugs 0.000 description 1
- 229920001038 ethylene copolymer Polymers 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 239000002874 hemostatic agent Substances 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229920000554 ionomer Polymers 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 239000005001 laminate film Substances 0.000 description 1
- 238000010030 laminating Methods 0.000 description 1
- 239000011344 liquid material Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 238000000465 moulding Methods 0.000 description 1
- 230000003533 narcotic effect Effects 0.000 description 1
- IAIWVQXQOWNYOU-FPYGCLRLSA-N nitrofural Chemical compound NC(=O)N\N=C\C1=CC=C([N+]([O-])=O)O1 IAIWVQXQOWNYOU-FPYGCLRLSA-N 0.000 description 1
- 229960001907 nitrofurazone Drugs 0.000 description 1
- 229920001225 polyester resin Polymers 0.000 description 1
- 239000004645 polyester resin Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000002244 precipitate Substances 0.000 description 1
- OIGNJSKKLXVSLS-VWUMJDOOSA-N prednisolone Chemical compound O=C1C=C[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 OIGNJSKKLXVSLS-VWUMJDOOSA-N 0.000 description 1
- 229960002800 prednisolone acetate Drugs 0.000 description 1
- 238000003825 pressing Methods 0.000 description 1
- 229960001309 procaine hydrochloride Drugs 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 235000008160 pyridoxine Nutrition 0.000 description 1
- 239000011677 pyridoxine Substances 0.000 description 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 238000004626 scanning electron microscopy Methods 0.000 description 1
- 239000012056 semi-solid material Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 229940042585 tocopherol acetate Drugs 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Abstract
(57)【要約】本公報は電子出願前の出願データであるた
め要約のデータは記録されません。(57) [Summary] This bulletin contains application data before electronic filing, so abstract data is not recorded.
Description
【発明の詳細な説明】
(産業上の利用分野)
本発明はPTP包装材、特に流体、ウェットな固形物又
は半固形物、吸湿性を有する物質、水分の影響を受けや
すい物等の液状又は吸湿性物質を内容物とする各種製剤
に適したPTP包装材を用いた各種包装製剤に関する。Detailed Description of the Invention (Industrial Field of Application) The present invention is applicable to PTP packaging materials, particularly for liquid or semi-solid materials such as fluids, wet solids or semi-solids, hygroscopic substances, and materials susceptible to moisture. The present invention relates to various packaging preparations using PTP packaging material suitable for various preparations containing hygroscopic substances.
(従来の技術)
PTP包装(プレス・スルー・パンク)は錠剤や菓子類
、料理用材料等の包装に広く用いられている。これは、
内容物を型どって成形したポリ塩化ビニル環装の部材(
以下プリスター部材という)の裏側をアルミニウム箔又
はコーティングアルミニウム箔(以下シール部材という
)でヒートシールしたものである。(Prior Art) PTP packaging (press-through-punk) is widely used for packaging tablets, confectionery, cooking ingredients, and the like. this is,
A polyvinyl chloride ring molded by molding the contents (
The back side of the pristar member (hereinafter referred to as the pristar member) is heat-sealed with aluminum foil or coated aluminum foil (hereinafter referred to as the seal member).
(発明が解決しようとする問題点)
しかしながら、シール部材のアルミニウム箔やコーティ
ングアルミニウム箔はピンホール等のため防湿の信軌性
が低く、又プリスター部材のポリ塩化ビニル等も透湿度
が比較的高いため(例えば30μmの厚さの硬質ポリ塩
化ビニルの透湿度は29〜34g/w”/24hr、)
、内容物が流体、ウエントナ固形物又は半固形物(ゼ
リー、ゲル等)、吸湿性を有する物質、水分の影響を受
けやすい物(錠剤、ドロップ等)等である場合のPTP
包装材としては問題があった。即ち、シール部材のアル
ミニウム箔の腐食及び/又は内容物の変色、変質等が生
じ、特に内容物が液剤や吸湿性を有する錠剤等である場
合、分解、変色、固化、潮解等を起こし薬物の効能・効
果が損なわれるため、これまではメタルパンク(錠剤を
両側からポリエチレンフィルムをラミネートしたアルミ
ニウム箔で挟み、ヒートシールしたもの)により供され
てきた。しかしながら、メタルバックは内容物を外部よ
り観察することができないため、調剤特等内容物の異常
を察知できない等の問題を有していた。(Problems to be Solved by the Invention) However, the sealing member's aluminum foil and coating aluminum foil have low moisture-proof reliability due to pinholes, etc., and the pristar member's polyvinyl chloride has relatively high moisture permeability. (For example, the moisture permeability of hard polyvinyl chloride with a thickness of 30 μm is 29 to 34 g/w”/24 hr.)
, PTP when the contents are fluids, solid or semi-solid substances (jelly, gel, etc.), hygroscopic substances, substances susceptible to moisture (tablets, drops, etc.), etc.
There was a problem with the packaging material. In other words, corrosion of the aluminum foil of the sealing member and/or discoloration or deterioration of the contents may occur, and especially if the contents are liquid drugs or hygroscopic tablets, decomposition, discoloration, solidification, deliquescence, etc. may occur, and the drug may deteriorate. Until now, it has been provided in a metal-puncture form (a tablet sandwiched between aluminum foil laminated with polyethylene film on both sides and then heat-sealed) to prevent its efficacy and efficacy from being compromised. However, since metal bags cannot observe the contents from the outside, they have had problems such as the inability to detect abnormalities in the contents of special preparations.
更に、近年開発されてつつある流動性を有する薬剤をP
TP包装にて封入した薬剤内包教急バンデージ(例えば
特開昭61−22451号参照)などの場合、従来のア
ルミニウム箔は勿論、コーティングアルミニウム箔をP
TP包装のシール部材として用いても加速試験〔40℃
、75%RH(相対温度)で6力月以上経時変化を起こ
さないことが必要〕に耐えることができない0例えばコ
ーティングアルミニウム箔を使用する場合であっても、
コーティング層にはしばしばピンホールやクランクがあ
り実質的に非孔性ではないため(このことは走査型電子
顕微鏡による観察により容易に確かめられる)、時間と
共にそこから浸潤した薬液によってアルミニウム箔が腐
食し、又内容物の変色、変質等を起こすなどしてしまう
。Furthermore, drugs with fluidity that have been developed in recent years are
In the case of drug-containing Kyokyu bandage sealed in TP packaging (for example, see JP-A No. 61-22451), not only conventional aluminum foil but also coated aluminum foil can be used.
Accelerated test [40°C] when used as a sealing member for TP packaging
For example, even when using coated aluminum foil,
Because the coating layer often has pinholes and cracks and is not substantially non-porous (this is easily confirmed by scanning electron microscopy), chemicals that seep through the coating layer can corrode the aluminum foil over time. , and may cause discoloration or deterioration of the contents.
(問題点を解決するための手段)
本発明者は内容物が流体、ウェットな固形物又は半固形
物、吸湿性を有する物質、水分の影響を受けやすい物等
の液状又は吸湿性物質であってもシール部材が腐食した
り、内容物の、変色、変質、固化、潮解、沈澱等が起こ
らないPTP包装材を鋭意研究した結果、熱可塑性樹脂
をラミネート加工したシール部材、更にはシール部材・
プリスター部材両方共にラミネート加工したPTP包装
材が前記液状又は吸湿性物質の包装材に非常に好適で種
々の条件を満足するものであることを見出し、本発明を
完成した。(Means for Solving the Problem) The present inventor has proposed that the content may be a liquid or hygroscopic substance such as a fluid, a wet solid or semi-solid, a hygroscopic substance, or a substance susceptible to moisture. As a result of intensive research into PTP packaging materials that do not cause corrosion of the sealing material or discoloration, deterioration, solidification, deliquescence, precipitation, etc. of the contents, we have developed a sealing material laminated with thermoplastic resin, as well as sealing materials and
The present invention was completed based on the discovery that a PTP packaging material in which both pristar members are laminated is very suitable for packaging the liquid or hygroscopic substances and satisfies various conditions.
即ち、熱可塑性樹脂をラミネート加工したシール部材、
例えばアルミニウム箔、セロハン、紙類(合成紙を含む
)は、熱可塑性樹脂が実質的な非孔性膜を形成するため
、シール部材が腐食したり、内容物の変色、変質、固化
、潮解、沈澱等が起こらない(耐食・防湿性)。ポリ塩
化ビニル、アセテート、ポリスチレン環装のプリスター
部材にも熱可塑性樹脂をラミネート加工した場合防湿性
は更に顕著となる。又、ラミネート加工したシール部材
はプリスター部材とのシールもし易く且つ強度も適度で
ある(シール適性・)、シール適性もプリスター部材に
シール部材にラミネート加工したのと同−又は異なった
熱可塑性樹脂をラミネート加工した場合に特に顕著で好
ましい、更に、これらの場合内容物の取り出しにも困難
を伴わないが(易取出性)、特にシール部材がアルミニ
ウム箔の時が最も好ましい。That is, a seal member laminated with thermoplastic resin,
For example, with aluminum foil, cellophane, and paper (including synthetic paper), the thermoplastic resin forms a substantially non-porous membrane, so the sealing member may corrode or the contents may discolor, change in quality, harden, deliquesce, or Precipitation does not occur (corrosion resistance/moisture resistance). Moisture resistance becomes even more remarkable when thermoplastic resin is laminated to polyvinyl chloride, acetate, or polystyrene ring-ringed pristar members. In addition, the laminated sealing member is easy to seal with the pristar member and has appropriate strength (sealing suitability).The sealing suitability is also the same or different thermoplastic resin used for laminating the sealing member on the pristar member. It is particularly preferable when laminated, and furthermore, in these cases there is no difficulty in taking out the contents (easy removal), but it is most preferable when the sealing member is made of aluminum foil.
本発明に利用されるラミネート加工は、通常の接着剤ラ
ミネート加工(湿式、乾式又は加熱溶解式ラミネート加
工)、押し出しラミネート加工いずれでもよいが、ラミ
ネート皮膜の厚さを薄りシ易いこと、接着剤が不要であ
ること、溶剤・希釈剤等の蒸発、乾燥等の工程を要しな
いことなどから、特に押し出しラミネート加工が好まし
い。The lamination process used in the present invention may be either normal adhesive lamination process (wet type, dry type or heat-melt lamination process) or extrusion lamination process, but it is important to note that the thickness of the laminate film can be easily thinned. Extrusion lamination is particularly preferred because it eliminates the need for processes such as evaporation of solvents and diluents, and drying.
熱可塑性樹脂はビニル系樹脂、ポリエステル系樹脂、セ
ルロースエステル系樹脂等いかなるものでもよいが、押
し出しラミネートには比較的溶融粘度の高いもの、例え
ば
・ポリエチレン(特に低密度ポリエチレン〔密度0.9
1〜0.93のポリエチン〕)
商品名:「スミカセン」 (登録商標−住友化学)、「
ミラソン」 (登録商標−三井ポリケミカル)、「ユカ
ロン」 (登録商標−三菱油化)、rNUcポリエチレ
ン」 (登録商標−日本ユニカー)、「旭ダウポリエチ
レン」 (商標−旭ダウ)、rUBEポリエチレン」
(登録商標−宇部興産)、「ベトロセン」 (登録商標
−日本ポリケミカル)等
・ポリプロピレン
商品名:「三菱ノーブレン」 (登録商標−三菱油化)
、「三井ノーブレン」 (商標−三井東圧化学)、「チ
ンソボリプロ」 (登録商標−チッソ石油化学)等
・アイオノマー
商品名:「サーリンAJ (登録商標−デュポン)等
・エチレン共重合体
商品名:「エルバフクス」 (登録商標−デュポン)等
が好ましい。又、シール部材にラミネート加工する熱可
塑性樹脂の厚さは5乃至30μmであることが易取出性
上好ましい。The thermoplastic resin may be of any type, such as vinyl resin, polyester resin, cellulose ester resin, etc., but for extrusion lamination, resins with relatively high melt viscosity, such as polyethylene (especially low density polyethylene [density 0.9
1 to 0.93 polyethin]) Product name: "Sumikasen" (registered trademark - Sumitomo Chemical), "
"Mirason" (registered trademark - Mitsui Polychemicals), "Yukalon" (registered trademark - Mitsubishi Yuka), "rNUc polyethylene" (registered trademark - Nippon Unicar), "Asahi Dow polyethylene" (trademark - Asahi Dow), "rUBE polyethylene"
(registered trademark - Ube Industries), "Betrocene" (registered trademark - Nippon Polychemical), etc. Polypropylene product name: "Mitsubishi Noblen" (registered trademark - Mitsubishi Yuka)
, "Mitsui Noblen" (trademark - Mitsui Toatsu Chemical), "Chinsoboripro" (registered trademark - Chisso Petrochemical), etc. Ionomer product name: "Surlyn AJ (registered trademark - DuPont) etc." Ethylene copolymer product name: "``Erbafuchs'' (registered trademark - DuPont) and the like are preferred. Further, it is preferable that the thickness of the thermoplastic resin laminated onto the sealing member is 5 to 30 μm from the viewpoint of easy removal.
(作用)
本発明ラミネート加工PTP包装材を用いた各種包装製
剤は、ラミネート加工された熱可塑性樹脂が流体等の内
容物のシール部材への浸潤、又は外気中の水蒸気の内部
への浸入を防ぐことにより、シール部材の腐食、内容物
の変質等を防止できるばかりでなく、内容物を外部より
観察できる。(Function) In various packaging preparations using the laminated PTP packaging material of the present invention, the laminated thermoplastic resin prevents contents such as fluid from infiltrating into the sealing member or water vapor in the outside air from infiltrating into the interior. This not only prevents corrosion of the sealing member and deterioration of the contents, but also allows the contents to be observed from the outside.
(実施例)
以下、本発明ラミネート加工PTP包装材を用いた各種
包装製剤の一実施例について図面に従って説明するが、
本発明はこれに限定されるものではない。(Example) Hereinafter, an example of various packaging preparations using the laminated PTP packaging material of the present invention will be described according to the drawings.
The present invention is not limited to this.
第1図は薬剤内包救急バンデージの断面図であり、■は
パッド2を装着した粘着シートであり、バンド上部には
薬剤3が、薬剤被覆膜5とI+離レシート4配設された
プリスター部6とで形成された空間内に内包されている
。当該プリスター部6には凹状突起8が、又、粘着シー
ト1の一端には剥離シートを剥がし易くするためのセパ
レータ7が設けられている。Fig. 1 is a cross-sectional view of a drug-containing emergency bandage, where ■ is an adhesive sheet with a pad 2 attached, a drug 3 is attached to the upper part of the band, and a pristar part on which a drug coating film 5 and an I + release receipt 4 are arranged. It is contained within the space formed by 6 and 6. The pristar portion 6 is provided with a concave projection 8, and one end of the adhesive sheet 1 is provided with a separator 7 for making the release sheet easier to peel off.
ここで、剥離シート4と薬剤被覆膜5はPTP包装され
ている。第2図に示すとおり、薬剤被覆膜5は厚さ約2
0μmのアルミニウム箔9に厚さ&’l15μmの低密
度ポリエチレンlOを押し出しラミネート加工して成形
し、又、第3図に示すとおり、剥離シート4は厚さ約2
00μmのポリ塩化ビニル11の裏面(薬剤被覆膜と向
かい合う側)に厚さ約50μmの低密度ポリエチレン1
0を押し出しラミネート加工して成形した。薬剤被覆膜
5と剥離シート4はヒートシール゛にて接合された。Here, the release sheet 4 and the drug coating film 5 are packaged in PTP. As shown in FIG. 2, the drug coating film 5 has a thickness of about 2
0 μm aluminum foil 9 is extruded and laminated with low density polyethylene 10 having a thickness of 15 μm, and as shown in FIG. 3, the release sheet 4 has a thickness of about 2
Low density polyethylene 1 with a thickness of about 50 μm is placed on the back side of the polyvinyl chloride 11 with a thickness of 00 μm (the side facing the drug coating film).
0 was extruded and laminated and molded. The drug coating film 5 and the release sheet 4 were bonded together by heat sealing.
上記救急バンデージに内包される薬剤3としては、外用
剤であれば何でもよく、例えば殺菌消毒剤として、グル
コン酸クロルヘキシジン、塩化ベンザルコニウム、クロ
ルヘキシレノール、アクリノール、チアントール、塩化
デカリニウム、スルファミン、スルファミン、ニトロフ
ラゾン、ホウ酸、ホモスルファミン、トリクロカルパン
等があり、創傷部収斂治療促進剤として酸化亜鉛、塩酸
ピリドキシン、酢酸トコフェロール、シバルミチン酸ピ
リドキシン、止血剤として塩酸ナハアゾリン、硫酸亜鉛
、塩酸エフェドリン等、抗炎症剤としてはプレドニゾロ
ン、デキサメサゾン、酢酸コルチゾン等のステロイド剤
、グリチルレチン酸、塩化リゾチーム等、抗ヒスタミン
剤としてマレイン酸クロルフェニラミン、塩酸ジフェン
ヒドラミン等がある。又、局麻剤としてはりドカイン、
アミノ安息香酸エチル、塩酸プロカイン、塩酸ジブカイ
ン、塩酸テ上うカイン、塩酸バラブチルアミノ安息香酸
ジエチルアミノエチル等がある。The medicine 3 contained in the above-mentioned emergency bandage may be any external medicine, such as sterilizing disinfectants such as chlorhexidine gluconate, benzalkonium chloride, chlorhexylenol, acrinol, thianthol, dequalinium chloride, sulfamine, sulfamine, These include nitrofurazone, boric acid, homosulfamine, triclocarpane, etc.; zinc oxide, pyridoxine hydrochloride, tocopherol acetate, pyridoxine cibalmitate as agents for promoting wound convergence; anti-inflammatory agents such as nahazoline hydrochloride, zinc sulfate, ephedrine hydrochloride, etc. as hemostatic agents. Examples of agents include steroids such as prednisolone, dexamethasone, and cortisone acetate; glycyrrhetinic acid and lysozyme chloride; and antihistamines such as chlorpheniramine maleate and diphenhydramine hydrochloride. In addition, acupuncture is used as a topical narcotic,
Examples include ethyl aminobenzoate, procaine hydrochloride, dibucaine hydrochloride, tecaine hydrochloride, and diethylaminoethyl valbutylaminobenzoate hydrochloride.
本発明ラミネート加工PTP包装材を用いた上記薬剤内
包救急バンデージは、内容物として上記薬剤中復数のも
のを配合剤として内包させたが、厚生省の定める加速試
験条件下にて6力月以上シール部材が腐食せず、又内包
された薬剤も変色、沈澱、配合比変化等しないことが確
認された。これに対し、化アルミニウム箔及びコーティ
ングアルミニウムM(3回塗り等の厚塗りしたものを含
む)では1力月経過時点で既に内容物、シニル部材の変
色を起こし、更に5力月経過時点の定量では内容物の配
合比の変化をきたし、全体の重量も減少していることが
確認された。The above-mentioned drug-containing emergency bandage using the laminated PTP packaging material of the present invention contains multiple numbers of the above-mentioned drugs as a compounded drug, but it was sealed for more than 6 months under the accelerated test conditions specified by the Ministry of Health and Welfare. It was confirmed that the components did not corrode, and the encapsulated drug did not change color, precipitate, or change the blending ratio. On the other hand, with aluminum foil and coated aluminum M (including those coated thickly such as 3 coats), the contents and aluminum parts have already discolored after 1 month, and furthermore, after 5 months have passed, the amount of It was confirmed that the blending ratio of the contents changed and the overall weight decreased.
ラミネート加工された薬剤被覆膜5は、ブリスター−6
を指で押圧することにより容易に破壊され、薬剤3はス
ムーズにパッド2に移行した。The laminated drug coating film 5 is a blister-6
was easily destroyed by pressing with a finger, and the drug 3 was smoothly transferred to the pad 2.
(発明の効果)
上述の如く、本発明ラミネート加工PTP包装材を用い
た各種包装製剤は内容物によるシール部材の腐食及び内
容物変色、変質、固化、潮解、重量変化等を防ぎ、又内
容物を外部より観察できる。(Effects of the Invention) As described above, various packaging preparations using the laminated PTP packaging material of the present invention prevent the contents from corroding the sealing member and the contents from discoloration, deterioration, solidification, deliquescence, weight change, etc. can be observed from the outside.
更に、シール適性もよく、内容物の取り出しも容易であ
る。従って、内容物が流体、ウェットな固形物又は半固
形物、吸湿性を有する物質、水分の影響を受けやすい物
等の液状又は吸湿性物質である場合には特に優れた包装
材として広範な分野に利用可能である。Furthermore, it has good sealability and is easy to take out the contents. Therefore, when the contents are liquid or hygroscopic substances such as fluids, wet solids or semi-solids, hygroscopic substances, substances susceptible to moisture, etc., it is an excellent packaging material that can be used in a wide range of fields. is available.
第1図は本発明ラミネート加工PTP包装材を用いた薬
剤内包救急バンデージの断面図であり、第2図及び第3
図は各々薬剤被覆膜、ブリスターの各拡大断面図である
。
1・・粘着シート 2・・パッド
3・・薬剤 4・・剥離シート5・・薬剤被覆
膜 6・・ブリスター9・・硬質アルミニウム箔
lO・・低密度ポリエチレン
11・・ポリ塩化ビニルFigure 1 is a sectional view of a drug-containing emergency bandage using the laminated PTP packaging material of the present invention, and Figures 2 and 3 are
The figures are enlarged cross-sectional views of a drug-coated membrane and a blister, respectively. 1.Adhesive sheet 2.Pad 3.Drug 4.Release sheet 5.Drug coating film 6.Blister 9.Hard aluminum foil lO.Low density polyethylene 11.Polyvinyl chloride
Claims (2)
PTP包装材を用いることを特徴とする各種包装製剤。(1) Various packaging preparations characterized by using a PTP packaging material laminated with thermoplastic resin as a sealing member.
したPTP包装材を用いることを特徴とする特許請求の
範囲第1項記載の各種包装製剤。(2) Various packaging preparations according to claim 1, characterized in that a PTP packaging material in which a thermoplastic resin is laminated as a pristar member is used.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29121486A JPS63152564A (en) | 1986-12-05 | 1986-12-05 | Various packaged medicine |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP29121486A JPS63152564A (en) | 1986-12-05 | 1986-12-05 | Various packaged medicine |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63152564A true JPS63152564A (en) | 1988-06-25 |
Family
ID=17765941
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP29121486A Pending JPS63152564A (en) | 1986-12-05 | 1986-12-05 | Various packaged medicine |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63152564A (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03162263A (en) * | 1989-11-21 | 1991-07-12 | Canon Inc | Packing container |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4839276B1 (en) * | 1967-12-20 | 1973-11-22 | ||
JPS5984763A (en) * | 1982-11-01 | 1984-05-16 | 出光石油化学株式会社 | Package |
JPS61222451A (en) * | 1985-12-14 | 1986-10-02 | 日本臓器製薬株式会社 | Emergency bandage |
-
1986
- 1986-12-05 JP JP29121486A patent/JPS63152564A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS4839276B1 (en) * | 1967-12-20 | 1973-11-22 | ||
JPS5984763A (en) * | 1982-11-01 | 1984-05-16 | 出光石油化学株式会社 | Package |
JPS61222451A (en) * | 1985-12-14 | 1986-10-02 | 日本臓器製薬株式会社 | Emergency bandage |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH03162263A (en) * | 1989-11-21 | 1991-07-12 | Canon Inc | Packing container |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3419139B2 (en) | Flexible multi-chamber container | |
FI68201C (en) | PLASTIC FOUNDATION PLATE FOR FLASHING CHAMBER FOR WOOD | |
JP3016348B2 (en) | Double chamber container | |
US6620436B1 (en) | Mixing and dispensing package for a wound dressing | |
KR100277396B1 (en) | Therapeutic container | |
JPS62117739A (en) | Multilayer film and packaging for physiological solution using said film | |
AU700873B2 (en) | Childproof blister package with dessicant | |
JPS59501862A (en) | window bag for liquids | |
JP4965758B2 (en) | Packaging and use of dental materials | |
JPS61217244A (en) | Multilayer sheet material | |
JPS6324959A (en) | Partitioned percutaneous delivery system | |
JPS63152564A (en) | Various packaged medicine | |
JP3675019B2 (en) | Mixed packaging | |
CN100450767C (en) | Packaging for plaster contg. active ingredients | |
JPS63258773A (en) | Various packaged medicine | |
JPH09251U (en) | Drug-containing first aid bandage | |
JP2937565B2 (en) | Infusion container | |
WO2019093227A1 (en) | Cover material for blister packs | |
JP2787330B2 (en) | Semi-solid filling container for coating and coating container filled with semi-solid | |
JPH0444357Y2 (en) | ||
JPH1176367A (en) | Container for medical treatment | |
JP3730742B2 (en) | Packaging material for liquid medicine and method for producing the same | |
JPH1156970A (en) | Medical container | |
JPS607172Y2 (en) | Easy-open packaging | |
JPH0939987A (en) | Packaging bag with zipper |